[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"self-injurious-behavior\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:self-injurious-behavior":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,16,0,[8,63,97,120,153,185,216,251,277,306,331,359,387,416,441,466],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":17,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":45,"overallStatus":50,"whyStopped":4,"lastUpdateSubmitDate":51,"lastUpdatePostDateStruct":52,"startDateStruct":55,"completionDateStruct":57,"leadSponsor":59,"locationsCount":62},"100551600","natural-history-of-depression-bipolar-disorder-and-suicide-risk-100551600",false,"NCT06462196","Natural History of Depression, Bipolar Disorder and Suicide Risk","* INCLUSION CRITERIA:\n\nIn order to be eligible to participate in this study, an individual must meet all of the following criteria:\n\n* Signed consent for Protocol 01-M-0254: The Evaluation of Patients with Mood and Anxiety Disorders and Healthy Volunteers\n* Age 18 years or older\n* Able to provide informed consent\n* Able to read and write English\n\nEXCLUSION CRITERIA:\n\n* Unstable medical conditions in the opinion of the investigator that would preclude participation in outpatient or inpatient treatment.\n* Pregnancy\n* Participation in the Protocol 01-M-0254: The Evaluation of Patients with Mood and Anxiety Disorders and Healthy Volunteers, as a healthy volunteer.\n* Participants with a history of DSM-IV substance or alcohol abuse or dependence, or DSM-5 substance use disorder (except for caffeine, nicotine, or cannabis), or moderate to severe alcohol use disorder, within the preceding three months. In addition, participants who are currently using drugs (except for caffeine, nicotine, or cannabis) must not have used illicit substances or known drugs of abuse in the two weeks prior to consent and must have a negative drug urine test (except for prescribed benzodiazepines or stimulants) prior to enrolling in the study. Cannabis use is exclusionary if the use is daily, or if participants are unable to abstain during the study, or if function of daily life is impaired by use as determined by a clinician.","ALL","18 Years","120 Years",{"count":19,"type":20},500,"ESTIMATED","OBSERVATIONAL","Mood disorders, such as depression and bipolar disorder, are difficult to treat. One reason is that there are no objective ways to measure how these disorders affect the body and respond to different treatments. In this study, researchers want to perform tests on people undergoing clinical care for mood disorders. The purpose is to understand the experience of receiving treatment for depression, bipolar disorder, and suicide risk. We also hope that this study will help us to predict which medications will improve thoughts of suicide.\n\nPeople 18 years or older who are receiving treatment for depression, bipolar disorder, or suicide risk may take part in this study. Participants must have also been enrolled in protocol 01-M-0254.\n\nThis study will be conducted at the NIH Clinical Center in Bethesda, MD. The study typically lasts up to 12 weeks, but may last longer if a participant s treatment continues past that time.\n\nParticipants will have weekly interviews and questionnaires while they are being treated for their mood disorder. Other tests are optional and include psychological testing, blood draws, sleep tests, and imaging scans. These will be done at the start and the end of research participation.",[24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44],"Behavioral Symptoms","Suicide","Self-Injurious Behavior","Sensory System Agents","Analgesics","Peripheral Nervous System Agents","Physiological Effects of Drugs","Anesthetics, Dissociative","Anesthetics, General","Anesthetics","Central Nervous System Depressants","Excitatory Amino Acid Antagonists","Excitatory Amino Acid Agents","Neurotransmitter Agents","Molecular Mechanisms of Pharmacological Action","Ketamine","Depression, Unipolar","Depressive Symptoms","Treatment Resistant Depression","Major Depressive Disorder","Depression, Bipolar",[46,25,43,47,48,49,42],"Neurobiology","Bipolar Disorder","Biomarkers","Suicide Risk","RECRUITING","2026-06-26",{"date":53,"type":54},"2026-06-29","ACTUAL",{"date":56,"type":54},"2024-09-09",{"date":58,"type":20},"2030-06-01",{"name":60,"class":61},"National Institute of Mental Health (NIMH)","NIH",1,{"id":64,"slug":65,"hasResults":11,"nctId":66,"briefTitle":67,"officialTitle":68,"acronym":4,"eligibilityCriteria":69,"healthyVolunteers":11,"sex":15,"minAge":70,"maxAge":71,"enrollmentInfo":72,"targetDuration":4,"studyType":74,"phases":75,"briefSummary":77,"conditions":78,"keywords":80,"overallStatus":86,"whyStopped":4,"lastUpdateSubmitDate":87,"lastUpdatePostDateStruct":88,"startDateStruct":90,"completionDateStruct":92,"leadSponsor":94,"locationsCount":62},"100641619","using-apollo-neuro-in-autistic-children-with-self-injurious-behavior-100641619","NCT07648420","Using Apollo Neuro in Autistic Children With Self-Injurious Behavior","Feasibility and Usability of the Apollo Neuro, a Wearable Sensory Device, in Autistic Children With Self-Injurious Behavior","Inclusion Criteria for child:\n\n* Diagnosis of autism spectrum disorder (ASD), as reported by caregiver\n* Presence of self-injurious behavior, as reported by caregiver\n* Demonstrates sensory over and\u002For under- responsivity\n* Aged 6 years to 14 years, 11 months (179 months) at the time of enrollment\n* Has a caregiver willing and able to provide consent and participate in study procedures\n\nExclusion Criteria for child:\n\n* Has medical condition that may increase risk with use of a wearable nibrotactile device, including:\n\n  * implanted medical or neurological devices (e.g., pacemaker)\n  * significant cardiac conditions or arrhythmias\n  * history of syncope (fainting)\n* Known seizure disorder without physician clearance\n* Regular use of nibrotactile or autonomic- modulating wearable devices within the past 90 days\n* Any condition that, in the judgment of the investigator, would interfere with safe participation or interpretation of study procedures\n\nInclusion Criteria for Caregiver:\n\n* Parent or legal guardian of the enrolled child participant\n* Able to provide informed consent in English\n* Able and willing to support device use according to study protocol and complete study-related data collection\n* Has access to a smartphone or compatible device capable of operating the Apollo Neuro application for the duration of study period\n\nExclusion Criteria for Caregiver:\n\n• Unable to provide informed consent in English","6 Years","179 Months",{"count":73,"type":20},18,"INTERVENTIONAL",[76],"NA","This study will evaluate the feasibility and acceptability of the Apollo Neuro, a wearable vibrotactile sensory device, in autistic children who engage in self-injurious behavior (SIB).\n\nParticipants will wear the device for at least 3 hours per day over a 30-35 day period with caregiver support. Outcomes will include adherence to device use, caregiver-reported feasibility and acceptability, and descriptive characterization of caregiver-reported self- injurious and repetitive behaviors during the study period. This preliminary, single-group study is not designed to evaluate efficacy and will inform the design of future controlled trials.",[26,79],"Autism Spectrum Disorder",[81,82,83,84,85],"Apollo Neuro Device","Sensory Responsivity","Autonomic Regulation","Wearable Device","Vibrotactile Stimulation","NOT_YET_RECRUITING","2026-06-15",{"date":89,"type":54},"2026-06-17",{"date":91,"type":20},"2026-07",{"date":93,"type":20},"2026-11",{"name":95,"class":96},"Virginia Commonwealth University","OTHER",{"id":98,"slug":99,"hasResults":11,"nctId":100,"briefTitle":101,"officialTitle":102,"acronym":4,"eligibilityCriteria":103,"healthyVolunteers":11,"sex":15,"minAge":104,"maxAge":105,"enrollmentInfo":106,"targetDuration":4,"studyType":74,"phases":108,"briefSummary":109,"conditions":110,"keywords":4,"overallStatus":50,"whyStopped":4,"lastUpdateSubmitDate":87,"lastUpdatePostDateStruct":113,"startDateStruct":114,"completionDateStruct":116,"leadSponsor":118,"locationsCount":62},"100366002","refinements-of-functional-communication-training-100366002","NCT04045600","Refinements of Functional Communication Training","Stimulus Control Refinements of Functional Communication Training","Inclusion Criteria:\n\n* Boys and girls from ages 3 to 17\n* Destructive behavior that occurs at least 10 times a day despite previous treatment\n* Destructive behavior reinforced by social consequences like attention (FCT is not appropriate for automatically reinforced destructive behavior)\n* On a stable psychoactive drug regimen for at least 10 half-lives per drug or drug free\n* Stable educational plan and placement with no anticipated changes during the child's treatment\n\nExclusion Criteria:\n\n* Patients who do not meet the inclusion criteria\n* Patients currently receiving 15 or more hours per week of treatment for their destructive behavior\n* DSM-5 diagnosis of Rett syndrome or other degenerative conditions (e.g., inborn error of metabolism)\n* A comorbid health condition or major mental disorder that would interfere with study participation\n* Occurrence of SIB during study assessments that presents a risk of serious or permanent harm (e.g., detached retinas) based on our routine clinical-risk assessment\n* Patients requiring drug-treatment changes, but the experimenters will invite these patients to participate if they meet inclusion criteria after drug regimen is stable.","3 Years","17 Years",{"count":107,"type":20},24,[76],"Although treatments for problem behavior, like functional communication training (FCT), can be highly effective in the clinic, changes in the way the FCT is implemented (e.g., when transferring treatment to the home, when teachers implement treatment with poor fidelity) can result in treatment relapse. The goal of this study is to evaluate whether using treatment signals and gradually introducing materials from natural contexts can help mitigate treatment relapse during context changes and poor treatment-integrity scenarios.",[111,112],"Aggression","Self-injurious Behavior",{"date":89,"type":54},{"date":115,"type":54},"2021-05-03",{"date":117,"type":20},"2026-12-31",{"name":119,"class":96},"Rutgers, The State University of New Jersey",{"id":121,"slug":122,"hasResults":11,"nctId":123,"briefTitle":124,"officialTitle":125,"acronym":4,"eligibilityCriteria":126,"healthyVolunteers":11,"sex":15,"minAge":127,"maxAge":4,"enrollmentInfo":128,"targetDuration":4,"studyType":74,"phases":130,"briefSummary":131,"conditions":132,"keywords":134,"overallStatus":86,"whyStopped":4,"lastUpdateSubmitDate":143,"lastUpdatePostDateStruct":144,"startDateStruct":146,"completionDateStruct":148,"leadSponsor":150,"locationsCount":152},"100643420","naltrexone-for-nonsuicidal-self-injury-100643420","NCT07641283","Naltrexone for Nonsuicidal Self-Injury","A Randomized, Double-Blinded Clinical Trial to Evaluate the Effectiveness of Naltrexone in Improving Nonsuicidal Self-Injurious Behavior","Inclusion Criteria:\n\n* Participants must meet all of the following criteria:\n\n  1. Individuals aged 16 years or older.\n  2. Individuals with clinically significant nonsuicidal self-injurious behavior.\n  3. Individuals who are able to understand the study procedures and provide written informed consent. For minors, consent from a legal guardian and assent from the participant will be obtained according to applicable regulations.\n  4. Individuals who are able to comply with study procedures, including clinical visits, medication administration, and study assessments.\n  5. Women of childbearing potential must have a negative urine pregnancy test at screening and agree to use appropriate contraception during the study period.\n\nExclusion Criteria:\n\n* Participants meeting any of the following criteria will be excluded:\n\n  1. Current serious suicidal ideation or high suicide risk, as determined by the investigator.\n  2. Current opioid use, opioid dependence, or use of opioid-containing medications.\n  3. Current use of opioid antagonists or medications that may interact with naltrexone, including methadone or buprenorphine.\n  4. Use of naltrexone within 1 week before screening.\n  5. Positive naloxone challenge test or positive urine opioid test, if applicable.\n  6. Known hypersensitivity to naltrexone or any component of the investigational product.\n  7. Active liver disease, active hepatitis, or clinically significant hepatic impairment.\n  8. Clinically significant renal impairment.\n  9. Pregnancy or breastfeeding.\n  10. Intellectual disability, organic brain disorder, or other condition that may interfere with the participant's ability to understand study procedures or complete assessments.\n  11. Inability to read or write Korean sufficiently to complete study assessments.\n  12. Documented prior non-response to naltrexone for nonsuicidal self-injury, as judged by the investigator.\n  13. Any other clinically significant medical or psychiatric condition that, in the opinion of the investigator, would make participation inappropriate or unsafe.","16 Years",{"count":129,"type":20},150,[76],"This randomized, double-blinded, placebo-controlled clinical trial aims to evaluate the efficacy and safety of naltrexone in reducing nonsuicidal self-injurious behavior among individuals with nonsuicidal self-injury. Participants will be randomly assigned to receive either naltrexone plus treatment as usual or placebo plus treatment as usual for 6 weeks.\n\nThe primary objective is to determine whether naltrexone reduces the frequency of nonsuicidal self-injurious behavior compared with placebo. Secondary objectives include evaluating changes in clinical severity, suicidal ideation, self-injury-related urges, ecological momentary assessment measures, and safety outcomes.",[133,26],"Nonsuicidal Self-Injury",[135,136,137,138,139,140,141,142],"Nonsuicidal self-injury","NSSI","Self-injurious behavior","Naltrexone","Opioid antagonist","Impulsivity","Suicidal ideation","Ecological momentary assessment","2026-06-08",{"date":145,"type":54},"2026-06-11",{"date":147,"type":20},"2026-06",{"date":149,"type":20},"2028-06",{"name":151,"class":96},"Seoul National University Hospital",3,{"id":154,"slug":155,"hasResults":11,"nctId":156,"briefTitle":157,"officialTitle":158,"acronym":159,"eligibilityCriteria":160,"healthyVolunteers":11,"sex":15,"minAge":161,"maxAge":105,"enrollmentInfo":162,"targetDuration":4,"studyType":74,"phases":164,"briefSummary":165,"conditions":166,"keywords":167,"overallStatus":50,"whyStopped":4,"lastUpdateSubmitDate":176,"lastUpdatePostDateStruct":177,"startDateStruct":179,"completionDateStruct":181,"leadSponsor":183,"locationsCount":62},"100609411","youth-empowerment-and-safety-intervention-100609411","NCT07214233","Youth Empowerment and Safety Intervention","Youth Empowerment and Safety Intervention for Systems-involved Sexual and Gender Minority Youth at Risk of Suicide","YES","Child Inclusion Criteria:\n\n* 12-17 years of age\n* Self-identify as a sexual or gender minority (SGM)\n* Involved in one or more system: juvenile justice, child welfare, and\u002For community-based mental health\n* Personal experience with self-injurious thoughts and behaviors (SITB)\n* English speaking\n* Willing and able to provide informed assent\n\nChild Exclusion Criteria:\n\n* Less than 12 or greater than 17 years of age (0-11 or 18 and over)\n* Do not self-identify as a sexual or gender minority (SGM)\n* Not involved in the juvenile justice, child welfare, and\u002For community-based mental health systems\n* No personal experience with self-injurious thoughts and behaviors (SITB)\n* Not English speaking\n* Unwilling and\u002For unable to provide informed assent\n\nCaregiver Inclusion Criteria:\n\n* 18-80 years of age\n* Primary Caregiver of youth who meet child inclusion criteria listed above\n* English speaking\n* Willing and able to provide informed consent\n\nCaregiver Exclusion Criteria:\n\n* Less than 18 or greater than 80 years of age (0-17 or 81 and over)\n* Not the Primary Caregiver of youth who meet child inclusion criteria listed above\n* Not English speaking\n* Unwilling and\u002For unable to provide informed consent","12 Years",{"count":163,"type":20},60,[76],"This clinical trial will implement and evaluate the feasibility, acceptability, and initial impact of Peer Support Specialist (PSS) services for public system-involved sexual and gender minority (lesbian, gay, bisexual, queer and\u002For transgender) youth (SGMY) at risk of suicide.",[25,26],[168,169,170,171,172,173,174,175],"Self-injurious thoughts and behaviors (SITB)","Peer Support Specialist (PSS)","Behavioral health","adolescent","LGBTQ","Juvenile Justice","Foster Care","Crisis Response","2026-05-06",{"date":178,"type":54},"2026-05-08",{"date":180,"type":54},"2026-02-23",{"date":182,"type":20},"2027-11-30",{"name":184,"class":96},"Case Western Reserve University",{"id":186,"slug":187,"hasResults":11,"nctId":188,"briefTitle":189,"officialTitle":190,"acronym":191,"eligibilityCriteria":192,"healthyVolunteers":11,"sex":15,"minAge":193,"maxAge":194,"enrollmentInfo":195,"targetDuration":4,"studyType":74,"phases":197,"briefSummary":198,"conditions":199,"keywords":202,"overallStatus":50,"whyStopped":4,"lastUpdateSubmitDate":209,"lastUpdatePostDateStruct":210,"startDateStruct":211,"completionDateStruct":213,"leadSponsor":214,"locationsCount":62},"100623370","youth-suicide-and-self-harm-intervention-clinical-and-biological-outcomes-study-100623370","NCT07395752","Youth Suicide and Self-Harm Intervention: Clinical and Biological Outcomes Study","Development and Biological Efficacy Validation of Youth Suicide and Self-Harm Intervention Program","SHIELD","Inclusion Criteria:\n\n1. General Criteria\n\n   * Aged between 15 and 30 years\n   * Obtained informed consent from a parent or legal guardian for participants under 19 years of age\n2. For the Self-Harm Group\n\n   * At least one incident of non-suicidal self-injury (NSSI) within the last 6 months\n   * Self-Harm Screening Inventory (SHSI) score of at least 1 (at least one \"Yes\" response)\n3. For the Suicide Attempt Group\n\n   * Suicide attempt within the last 6 months\n   * Depressive Symptom Inventory-Suicidality Subscale (DSI-SS) score of 3 or higher\n\nExclusion Criteria:\n\n1. Psychiatric and Developmental Conditions\n\n   * History of developmental disorders, including intellectual disability or autism spectrum disorder\n   * Diagnosis of schizophrenia or bipolar disorder\n   * Currently in an acute psychotic state\n2. Medical and Physical Conditions\n\n   * Presence of severe physical illness that interferes with daily life\n   * Presence of metallic substances in the body (e.g., cardiac pacemakers, artificial heart valves) that are incompatible with fMRI\n   * Diagnosis of claustrophobia\n   * Current Treatment and Intervention\n   * Currently receiving regular and active cognitive behavioral therapy (CBT)\n   * Initiation of pharmacological treatment within the last 2 months\n3. Communication and Consent\n\n   * Inability to communicate fluently in Korean\n   * Failure to obtain informed consent from a parent or legal guardian for participants under 19 years of age","15 Years","30 Years",{"count":196,"type":20},100,[76],"The goal of this clinical trial is to develop and evaluate youth-focused intervention programs for suicide and self-harm that are tailored to the psychological, developmental, and cultural characteristics of Korean adolescents and young adults. The study examines whether two structured, mindfulness-based intervention programs-one for middle and high school students and one for young adults-reduce suicidal ideation, self-harm behaviors, depressive symptoms, and emotion-regulation difficulties.\n\nThe study also aims to determine whether these clinical improvements are associated with biological changes, including alterations in resting-state functional brain activity (e.g., ALFF, ReHo, and functional connectivity) and social rhythm patterns.\n\nThe main questions this study seeks to answer are:\n\n* Does the youth suicide and self-harm intervention program reduce suicidal ideation and self-injurious thoughts\u002Fbehaviors?\n* Does the program improve mood, sleep, hopelessness, and emotion regulation?\n* Are improvements in clinical outcomes accompanied by changes in biological markers of suicide risk?\n* Researchers will compare the intervention program to usual care provided in hospitals, schools, and community mental health settings.\n\nParticipants will:\n\n* Participate in the structured suicide\u002Fself-harm intervention program or receive usual care.\n* Complete standardized assessments of mood, sleep, emotion regulation and suicide\u002Fself-harm risk.\n* Undergo biological assessments, including resting-state fMRI and rhythm-related measures, at baseline and follow-up.\n* Be followed for up to 12 weeks.",[200,26,201],"Suicidal Ideation","Suicide, Attempted",[203,141,204,205,206,207,208],"Youth suicide","Suicide attempt","fMRI","Social rhythm","Adolescents","Young adults","2026-05-04",{"date":178,"type":54},{"date":212,"type":54},"2025-07-30",{"date":117,"type":20},{"name":215,"class":96},"Ajou University School of Medicine",{"id":217,"slug":218,"hasResults":11,"nctId":219,"briefTitle":220,"officialTitle":221,"acronym":4,"eligibilityCriteria":222,"healthyVolunteers":11,"sex":15,"minAge":161,"maxAge":4,"enrollmentInfo":223,"targetDuration":4,"studyType":74,"phases":225,"briefSummary":226,"conditions":227,"keywords":230,"overallStatus":50,"whyStopped":4,"lastUpdateSubmitDate":241,"lastUpdatePostDateStruct":242,"startDateStruct":244,"completionDateStruct":246,"leadSponsor":248,"locationsCount":250},"100631882","integrating-the-youth-nominated-support-team-yst-with-cbt-for-black-youth-with-acute-suicide-risk-aim-2b-100631882","NCT07506460","Integrating the Youth Nominated Support Team (YST) With CBT for Black Youth With Acute Suicide Risk: Aim 2b","Integrating the Youth Nominated Support Team (YST) With CBT for Black Youth With Acute Suicide Risk","Youth Inclusion Criteria:\n\n* Patients that are able to provide at least one verifiable contact for emergency or tracking purposes\n* Willing to receive care at MiSide\n* Present to an acute emergency care setting with suicide risk (per protocol)\n* Self-identify as Black\n* Willing and able to complete enrollment procedures\n* Willing and able to provide signed and dated informed assent\n\nYouth Exclusion Criteria:\n\n* Unable to be consented in English\n* Do not have a parent\u002Flegal guardian available to provide consent\n* Are not able to provide informed assent or to participate in the assessment due to significant agitation, psychosis, cognitive impairment, learning disability, or medical trauma\n* Actively engaged in specialty mental health treatment\n* Participated in the Aim 2a open trial\n\nParent\u002FGuardian Inclusion Criteria:\n\n* Adults 18 years and older\n* The parent or legal guardian of a youth participating in this Aim\n* Understand written and spoken English\n* Willing and able to complete enrollment procedures\n* Willing and able to provide signed and dated informed consent\n* Need to have access to technology, either cell or an email address\n\nParent\u002FGuardian Exclusion Criteria:\n\n\\- Do not understand written and spoken English\n\nSupport Person Inclusion Criteria:\n\n* Adults 18 years and older\n* Understand written and spoken English\n* Approved to serve as a support person by the parent\u002Flegal guardian\n\nSupport Person Exclusion Criteria:\n\n* Do not understand written and spoken English\n* Not approved to serve as a support person by the parent\u002Fguardian",{"count":224,"type":20},90,[76],"This is a second pilot study being completed based on lessons learned from the Aim 2a feasibility pilot study (NCT06941311). Following modifications, the investigators are testing the acceptability, feasibility, and preliminary effectiveness of the combination of two psychosocial interventions, Cognitive Behavioral Therapy for Suicide Prevention (CBT-SP) and the computer-assisted version of the Youth-Nominated Support Team (eYST).\n\nIn this phase of the study, CBT-SP + eYST will be tested in an open trial (number of youth = 15). Investigators will recruit Black adolescents (ages 12-17) that come to an urban acute care setting for suicidal thoughts and\u002For self-injurious behaviors to receive the intervention in an outpatient community mental health agency. Participants will receive 12-14 sessions of CBT-SP in addition to YST. Participants will nominate up to 5 caring adults in their lives to serve as support persons. These support persons will attend an education\u002Forientation session to learn more about their role and how to support the youth. Support persons will have weekly contact with the youth and weekly follow up contacts from the youth's clinician\u002FYST intervention specialist.\n\nYouth will be assessed at baseline, 6 weeks, and 14 weeks. Parents will be assessed at baseline and 14 weeks. Support persons will be assessed at baseline and 14 weeks.\n\nFidelity assessments will be completed by clinicians after each session, after the YST psycho-ed session, and weekly to document contact with the support team.",[228,25,26,24,229],"Suicide Prevention","Behavior",[231,232,233,234,235,236,237,238,239,240],"Black youth","Acute suicide risk","Youth Nominated Support Team","Cognitive Behavioral therapy for Suicide Prevention","Community Mental Health","Suicide prevention","Behavior Therapy","Psychotherapy","Behavioral Disciplines and Activities","Cognitive Behavioral Therapy","2026-03-26",{"date":243,"type":54},"2026-04-01",{"date":245,"type":54},"2026-03-23",{"date":247,"type":20},"2026-08",{"name":249,"class":96},"University of Michigan",2,{"id":252,"slug":253,"hasResults":11,"nctId":254,"briefTitle":255,"officialTitle":256,"acronym":4,"eligibilityCriteria":257,"healthyVolunteers":11,"sex":15,"minAge":258,"maxAge":105,"enrollmentInfo":259,"targetDuration":4,"studyType":74,"phases":261,"briefSummary":262,"conditions":263,"keywords":264,"overallStatus":50,"whyStopped":4,"lastUpdateSubmitDate":245,"lastUpdatePostDateStruct":270,"startDateStruct":272,"completionDateStruct":274,"leadSponsor":275,"locationsCount":62},"100556766","deep-brain-stimulation-for-severe-self-injurious-behaviour-in-children-100556766","NCT06529380","Deep Brain Stimulation for Severe Self-Injurious Behaviour in Children","A Randomized Trial of Deep Brain Stimulation of the Nucleus Accumbens for Severe Self-Injurious Behaviours in Children","Inclusion Criteria:\n\n* Age 5-17 at the time of enrollment\n* DSM-5 diagnosis of Autism Spectrum Disorder\n* History of repetitive self-injurious behaviour, as reported by parents and documented on clinical assessment, either at the time of enrollment into the study or in prior medical records. The definition of self-injury is contextual, but requires ongoing, intermittent or continuous manifestation of self-mediated physical injury to the child.\n* Foreseeable risk of serious future self-harm.\n* Screening by study team for presence automatically reinforced self-injurious behaviour (ASIB) subtype 2 or subtype 3 based on caregiver history.\n* Failure or non-eligibility of medical therapy with ongoing repetitive self-injurious behaviours, at 6 months or more after initiation of therapy.\n* Parents or legal guardians, including caregivers, informed and able to provide written consent.\n* Able to comply with all testing, follow-up visits, and study appointments and protocols for 12 months following the end of the duration of the study.\n\nExclusion Criteria:\n\n* Substance dependence or abuse in the last 6 months, excluding caffeine and nicotine.\n* Any contraindication to MRI scanning.\n* Presence of cardiac arrhythmias, or other cardiac, respiratory, renal or endocrine conditions that may incur significant risk from a surgical procedure.\n* Pregnancy.","5 Years",{"count":260,"type":20},25,[76],"Deep Brain Stimulation for the Treatment of Severe Refractory Self-Injurious Behaviour in Children with Autism Spectrum Disorder: A Randomized Trial\n\nTo evaluate the effectiveness of deep brain stimulation (DBS) of the nucleus accumbens for the treatment of severe refractory, repetitive self-injurious behavior (SIB) in children with Autism Spectrum Disorder. Secondary objectives are to examine the effects of DBS on subtypes of SIB through functional analysis.",[26,79],[265,266,267,268,269],"deep brain stimulation","DBS","ASD","SIB","nucleus accumbens",{"date":271,"type":54},"2026-03-27",{"date":273,"type":54},"2024-09-11",{"date":117,"type":20},{"name":276,"class":96},"The Hospital for Sick Children",{"id":278,"slug":279,"hasResults":11,"nctId":280,"briefTitle":281,"officialTitle":282,"acronym":283,"eligibilityCriteria":284,"healthyVolunteers":11,"sex":15,"minAge":285,"maxAge":286,"enrollmentInfo":287,"targetDuration":4,"studyType":74,"phases":289,"briefSummary":290,"conditions":291,"keywords":293,"overallStatus":86,"whyStopped":4,"lastUpdateSubmitDate":298,"lastUpdatePostDateStruct":299,"startDateStruct":301,"completionDateStruct":302,"leadSponsor":304,"locationsCount":4},"100629834","a-text-based-expressive-writing-program-for-adolescents-at-risk-of-suicide-100629834","NCT07479823","A Text-Based Expressive Writing Program for Adolescents at Risk of Suicide","Effectiveness of a Text-Based Expressive Writing Intervention for Suicidal Adolescents and Young Adults: A Randomized Controlled Trial","WRITE-SAFE","Inclusion Criteria:\n\n* Adolescents or young adults aged 13 to 24 years.\n* Individuals with a history of suicidal ideation, suicide attempts, or non-suicidal self-injury.\n* Individuals currently receiving mental health services or who have been evaluated as having suicide risk within the past 6 months.\n* Ability to read and write in Korean.\n* For participants under 19 years of age, both participant assent and parental consent are required.\n\nExclusion Criteria:\n\n* Individuals requiring immediate psychiatric hospitalization.\n* Severe intellectual disability or neurodevelopmental disorder that prevents participation in writing activities.\n* Acute psychosis or manic episode that would interfere with participation in the study.\n* Participation in another suicide prevention clinical trial during the study period.","13 Years","24 Years",{"count":288,"type":20},160,[76],"The goal of this clinical trial is to learn if a structured expressive writing program can help reduce suicidal thoughts in adolescents and young adults who have experienced suicidal thoughts, suicide attempts, or self-harm. The study will include participants aged 13 to 24 years who are receiving mental health care or have recently been identified as being at risk for suicide.\n\nThe main questions the study aims to answer are:\n\n* Does a structured expressive writing program lower suicidal thoughts compared with usual care alone?\n* Does the program improve depression, impulsivity, and self-esteem?\n\nResearchers will compare participants who receive the expressive writing program together with treatment as usual to participants who receive treatment as usual alone.\n\nParticipants will:\n\n* Be randomly assigned to one of two groups: a writing program group or a usual care group\n* Complete questionnaires about mood, suicidal thoughts, and well-being at the start of the study, after 4 weeks, and after 8 weeks\n* If assigned to the writing program group, complete guided writing activities several times per week for 4 weeks. Each writing session will take about 15 to 20 minutes and will focus on understanding emotions, personal experiences, relationships, and meaning in difficult experiences.\n\nResearchers will study whether this writing program is a helpful and practical way to support young people who are experiencing suicidal thoughts or emotional distress.",[200,49,26,292],"Adolescent Mental Health",[294,228,295,296,297],"Expressive Writing","Adolescent Suicide","Self-Harm","Youth Mental Health","2026-03-13",{"date":300,"type":54},"2026-03-18",{"date":243,"type":20},{"date":303,"type":20},"2028-03",{"name":305,"class":96},"Hallym University Medical Center",{"id":307,"slug":308,"hasResults":11,"nctId":309,"briefTitle":310,"officialTitle":311,"acronym":312,"eligibilityCriteria":313,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":314,"targetDuration":4,"studyType":74,"phases":316,"briefSummary":317,"conditions":318,"keywords":319,"overallStatus":50,"whyStopped":4,"lastUpdateSubmitDate":321,"lastUpdatePostDateStruct":322,"startDateStruct":324,"completionDateStruct":326,"leadSponsor":328,"locationsCount":62},"100513715","self-injury-treatment-and-recovery-in-veterans-100513715","NCT05969080","Self-Injury Treatment and Recovery in Veterans","A Brief Intervention to Reduce Nonsuicidal Self-Injury and Improve Functioning in Veterans","STRIVe","Inclusion Criteria:\n\n* 18 years of age or older\n* Past service in the United States military\n* Nonsuicidal self-injury engagement on 2 occasions in past 30 days\n* Fluent in English\n* Able to provide voluntary informed consent\n\nExclusion Criteria:\n\n* Lifetime history of psychosis, mania, or hypomania\n* Imminent risk for suicide\u002Fhomicide warranting immediate intervention\n* Unable\u002Funwilling to complete study procedures",{"count":315,"type":20},40,[76],"Nonsuicidal self-injury (NSSI) refers to the intentional destruction of one's own body tissue without suicidal intent and for purposes that are not socially sanctioned. While NSSI has been understudied among Veterans, the lifetime prevalence rate of NSSI in Veterans is approximately three times higher than the general population. Moreover, NSSI is associated with increased risk for violence, psychiatric distress, and marked impairment in psychosocial functioning. Even though NSSI is distinct from suicidal behaviors in several important ways, NSSI remains a strong predictor of a future suicide attempt. The primary goal of this project is to evaluate the treatment and acceptability of a brief intervention for NSSI that aims to reduce psychosocial impairment and NSSI behaviors in Veterans.",[26],[26,320],"Veterans","2026-02-17",{"date":323,"type":54},"2026-02-19",{"date":325,"type":54},"2024-10-15",{"date":327,"type":20},"2027-03-31",{"name":329,"class":330},"VA Office of Research and Development","FED",{"id":332,"slug":333,"hasResults":11,"nctId":334,"briefTitle":335,"officialTitle":336,"acronym":337,"eligibilityCriteria":338,"healthyVolunteers":11,"sex":15,"minAge":285,"maxAge":16,"enrollmentInfo":339,"targetDuration":4,"studyType":74,"phases":341,"briefSummary":342,"conditions":343,"keywords":345,"overallStatus":50,"whyStopped":4,"lastUpdateSubmitDate":350,"lastUpdatePostDateStruct":351,"startDateStruct":353,"completionDateStruct":355,"leadSponsor":357,"locationsCount":62},"100571476","real-time-examination-of-skills-and-coping-use-in-teens-everyday-lives-100571476","NCT06720753","Real-time Examination of Skills and Coping Use in Teen's Everyday Lives","Examining Mechanisms of Change in Adolescent Self-Inflicted Injury","RESCUE","Inclusion Criteria:\n\n* 3+ incidents of self-inflicted injury (SII). At least one SII episode must score a minimum of \"3\" on lethality (moderate; e.g., overdose on 11-50 pills; deep cuts anywhere but neck) and \"4\" on intent (somewhat serious \\[about dying\\]) - even if aborted or interrupted. Adolescents with 3+ SIIs may also enroll if they have been hospitalized for suicide preparatory behavior.\n* English language proficiency\n* Access to a smart phone\n* Parent\u002Fcaregiver\u002Flegal guardian to participate with the adolescent\n\nExclusion Criteria:\n\n* Moderate to severe developmental or intellectual disability, psychosis, or a schizophrenia spectrum diagnosis.\n* Those taking medications with well-documented effects on psychophysiological responding.",{"count":340,"type":20},200,[76],"The goal of this clinical trial is to compare two core intervention skills among adolescents with a history of engaging in at least 3 lifetime incidents of self-inflicted injury (SII), at least one of which was a suicide attempt of at least moderate lethality and moderate intent to die. The main questions it aims to answer are:\n\nWhether and when youth use skills in daily life, how quickly skill use declines after teaching, and whether exposure to life stress influences skill learning and retention.\n\nThe Investigators also want to know whether brain-related, family-related, and physiology-related factors influence skills practice and any associated changes in self-harm\u002Fsuicide risk and emotion dysregulation.\n\nParticipants will complete surveys 5 times a day on their phones at baseline, and following each skill learning session. All participants will learn and practice the two skills with a parent while discussing topics they often argue about. During these discussions, participants will be hooked up to psychophysiological equipment to measure their cardiovascular functioning and their palm sweat. Participants' discussions will be coded for skill use and also for indices of family functioning. Approximately half of the participants will undergo two sets of fMRI scans to assess potential neural underpinnings of skill use.",[344,25],"Self Injurious Behavior",[344,346,347,25,207,348,205,349],"Dialectical Behavior Therapy","Therapy mechanisms","Families","Psychophysiological measures","2026-01-29",{"date":352,"type":54},"2026-01-30",{"date":354,"type":54},"2024-07-29",{"date":356,"type":20},"2029-03-31",{"name":358,"class":96},"University of Utah",{"id":360,"slug":361,"hasResults":11,"nctId":362,"briefTitle":363,"officialTitle":364,"acronym":365,"eligibilityCriteria":366,"healthyVolunteers":11,"sex":15,"minAge":285,"maxAge":16,"enrollmentInfo":367,"targetDuration":4,"studyType":74,"phases":368,"briefSummary":369,"conditions":370,"keywords":373,"overallStatus":86,"whyStopped":4,"lastUpdateSubmitDate":378,"lastUpdatePostDateStruct":379,"startDateStruct":381,"completionDateStruct":383,"leadSponsor":385,"locationsCount":62},"100618545","adapted-visual-safety-plan-for-autistic-youth-vsp-ay-to-address-self-harm-suicidal-ideation-and-suicide-behaviors-100618545","NCT07333014","Adapted Visual Safety Plan for Autistic Youth (VSP-AY) to Address Self-harm, Suicidal Ideation, and Suicide Behaviors","Adapted Visual Safety Plan for Autistic Youth (VSP-AY) to Address Self-harm, Suicidal Ideation, and Suicide Behaviors: : A Pilot Randomized Controlled Trial","VSP-AY","Inclusion Criteria:\n\n* Aged 13-18 years\n* Formal diagnosis of autism spectrum disorder\n* Experienced suicidal ideation or behavior within the past six months\n* Able to engage in the study intellectually, either verbally or in writing\n* Not at imminent risk of suicide requiring immediate hospitalization\n* Have adequate family support\n* Able to attend appointments at Geha Mental Health Center\n* Parent or legal guardian willing to provide informed consent\n* Adolescent willing to provide assent\n\nExclusion Criteria:\n\n* Immediate suicide risk requiring inpatient hospitalization\n* Active psychotic symptoms that prevent meaningful engagement\n* Active manic symptoms that prevent meaningful engagement\n* Insufficient Hebrew language proficiency to engage with study materials\n* Lack of family support, as documented by social services\n* Current participation in conflicting intervention studies",{"count":224,"type":20},[76],"This pilot randomized controlled trial will recruit 90 autistic adolescents aged 13-18 years with recent suicidal thoughts or behaviors from Geha Mental Health Center in Israel. Participants will be randomly assigned in a 1:1 ratio to either (1) the intervention group receiving the Visual Safety Plan for Autistic Youth (VSP-AY) plus standard care, or (2) the control group receiving treatment as usual without VSP-AY. Mental health professionals delivering VSP-AY will complete a 6-hour training with ongoing supervision throughout the study. Outcomes will be assessed at three timepoints: baseline (T0), immediately post-intervention (T1), and one-month follow-up (T2). The study will evaluate feasibility through recruitment and completion rates, acceptability through satisfaction questionnaires and qualitative interviews, and preliminary effectiveness through standardized measures of suicidal ideation (Columbia Suicide Severity Rating Scale), non-suicidal self-injury (NSSI-AT), and depression (Children's Depression Inventory).",[79,200,371,26,372],"Suicidal Behavior","Depression",[374,375,376,136,377],"Autistic adolescents","Visual safety plan","Self-harm","Mental health intervention","2025-12-31",{"date":380,"type":54},"2026-01-12",{"date":382,"type":20},"2026-07-30",{"date":384,"type":20},"2029-07-30",{"name":386,"class":96},"College of Management Academic Studies",{"id":388,"slug":389,"hasResults":11,"nctId":390,"briefTitle":391,"officialTitle":392,"acronym":4,"eligibilityCriteria":393,"healthyVolunteers":11,"sex":15,"minAge":394,"maxAge":395,"enrollmentInfo":396,"targetDuration":4,"studyType":74,"phases":397,"briefSummary":398,"conditions":399,"keywords":403,"overallStatus":50,"whyStopped":4,"lastUpdateSubmitDate":407,"lastUpdatePostDateStruct":408,"startDateStruct":410,"completionDateStruct":412,"leadSponsor":414,"locationsCount":250},"100614357","harnessing-communication-preferences-100614357","NCT07278544","Harnessing Communication Preferences","Harnessing Communication Preferences to Enhance Its Persistence and Mitigate Relapse of Challenging Behavior","Inclusion Criteria:\n\n* 2 years old and older.\n* Diagnosis of intellectual or developmental disability.\n* Referred for assessment and treatment of challenging behavior.\n\nExclusion Criteria:\n\n* Challenging behavior does not occur within the context of structured assessment, eliminating the ability to identify its operant function, or the behavior is deemed too dangerous to safely observe during assessment.\n* Communicate functionally using vocal\u002Fverbal communication.\n* Can only identify one proficient AAC strategy.","2 Years","90 Years",{"count":163,"type":20},[76],"The goal of this clinical trial is to evaluate how preference for communication approach (e.g., using a touch talker versus picture cards) impacts treatment maintenance in the context of treatment to reduce challenging behavior exhibited by individuals with intellectual and\u002For developmental disabilities. As well, the clinical trial will evaluate how this preference impacts treatment relapse when care providers implement intervention and will identify potential demographic variables (e.g., age and symptom severity) that affect outcomes.\n\nThe main question\\[s\\] it aims to answer \\[is\u002Fare\\]:\n\nPreferred communication strategies will persist to a greater extent when intervention is disrupted, relative to less preferred communication strategies.\n\nCommunication modality preference will increase persistence for individuals with lower pre-experimental symptom severity scores and higher pre-experimental communication functioning scores. We predict demographic characteristics and developmental level will not impact intervention outcomes.\n\nTwo groups will be compared. Group 1 will receive initial intervention using a preferred communication strategy. Group 2 will receive initial intervention using a non preferred, but effective, communication strategy. Intervention type will then be reversed. Researchers will compare preferred and non preferred interventions on continued expression of the communication strategy when intervention is challenged.\n\nParticipants will exhibit alternative appropriate communicative behavior as a means of replacing\u002Freducing challenging behavior. This will take place using (a) preferred communication strategies and (b) non preferred communication strategies. Following successful intervention with each type of communication, intervention will be challenged and continued use of the communication strategy will be measured.",[400,79,26,401,402],"Intellectual Disability","Communication Disabilities","Communication, Nonverbal",[404,405,406],"Functional communication training","Treatment maintenance","Behavioral relapse","2025-12-03",{"date":409,"type":54},"2025-12-12",{"date":411,"type":54},"2025-08-15",{"date":413,"type":20},"2031-03-31",{"name":415,"class":96},"Joel E. Ringdahl",{"id":417,"slug":418,"hasResults":11,"nctId":419,"briefTitle":420,"officialTitle":421,"acronym":4,"eligibilityCriteria":422,"healthyVolunteers":11,"sex":15,"minAge":161,"maxAge":423,"enrollmentInfo":424,"targetDuration":4,"studyType":74,"phases":426,"briefSummary":427,"conditions":428,"keywords":429,"overallStatus":50,"whyStopped":4,"lastUpdateSubmitDate":432,"lastUpdatePostDateStruct":433,"startDateStruct":435,"completionDateStruct":437,"leadSponsor":439,"locationsCount":62},"100586750","efficacy-of-triple-daily-15ma-tacs-on-adolescent-nssi-100586750","NCT06919432","Efficacy of Triple-daily 15mA tACS on Adolescent NSSI","Efficacy of Triple-daily 15mA Transcranial Alternating Current Stimulation on Adolescent Non-suicidal Self-injury (NSSI): a Double-blind, Randomized, Sham-controlled Trial","Inclusion Criteria:\n\n* Diagnosis of NSSI based on the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria section 3 diagnostic criteria.\n* Five or more NSSI episodes in the past year and at least one NSSI episode in the past month.\n* Age between 12 and 21 years.\n* Informed consent from parents or legal guardians.\n* Informed consent from participants aged 15 years and above.\n\nExclusion Criteria:\n\n* Current or history of organic brain disorders or neurological disorders.\n* Elevated or imminent suicidal risk, as assessed by clinicians during routine screening.\n* Previous or current exposure to electroconvulsive therapy (ECT), modified ECT, TMS, transcranial direct current stimulation (tDCS), tACS, or other neurostimulation treatments.\n* Presence of cochlear implants, cardiac pacemakers, implanted devices, or metal in the brain.\n* Previous or current use of psychotropic medication.\n* Pregnancy or lactation.\n* Participation in another concurrent clinical trial.\n* Refusal to provide informed consent to participate in the trial.\n* Other circumstances deemed unsuitable for participation by researchers.","21 Years",{"count":425,"type":20},66,[76],"In order to assess the clinical efficacy of triple-daily 15mA-tACS stimulation by comparing the effects of active and sham tACS interventions on driving improvements in adolescent Nonsuicidal Self-Injury(NSSI), participants will be randomly assigned to either the active or sham tACS group. This trial consists of a 2-week intensified intervention phase (40 sessions), followed by a 4-week observation period. The key hypothesis is that triple-daily 15mA-tACS stimulation will enhance clinical recovery compared to sham stimulation.",[26],[430,431],"Transcranial Alternating Current Stimulation (tACS)","non-invasive brain stimulation","2025-06-11",{"date":434,"type":54},"2025-06-12",{"date":436,"type":54},"2025-05-01",{"date":438,"type":20},"2027-09-30",{"name":440,"class":96},"Shanghai Mental Health Center",{"id":442,"slug":443,"hasResults":11,"nctId":444,"briefTitle":445,"officialTitle":445,"acronym":4,"eligibilityCriteria":446,"healthyVolunteers":11,"sex":15,"minAge":285,"maxAge":105,"enrollmentInfo":447,"targetDuration":4,"studyType":74,"phases":449,"briefSummary":450,"conditions":451,"keywords":452,"overallStatus":50,"whyStopped":4,"lastUpdateSubmitDate":457,"lastUpdatePostDateStruct":458,"startDateStruct":460,"completionDateStruct":462,"leadSponsor":463,"locationsCount":465},"100453064","teens-multi-site-trial-100453064","NCT05179655","TEENS Multi-site Trial","Inclusion Criteria:\n\n* ≥ 5 non-suicidal self-injury episodes in the past year and ≥ 1 non-suicidal self-injury episodes in the past month assessed by the Deliberate Self-Harm Inventory, Youth version (DSHI-Y).\n* Age-appropriate literacy assessed by referring clinicians and the self-injury team, i.e. age between 13 and 17.\n* Having at least one parent committing to participate in the parent program.\n* Informed consent from parents\u002Flegal caretakers and assent from participants above 15 years of age.\n\nExclusion Criteria:\n\n* Imminent suicidal risk assessed by clinicians during routine screening procedure (that can be rated as no risk, elevated risk, or imminent risk) in need of admission or other life saving strategies.\n* Lack of informed consent from parents\u002Flegal caretakers.\n* Lack of informed assent from the participant above 15 years of age.",{"count":448,"type":20},356,[76],"Emotion Regulation Individual Therapy for Adolescents, also called ERITA, is a youth friendly online therapy aiming to provide skills and train emotion regulation.\n\nThe aim of the TEENS Multi-site Trial is to investigate the effect of ERITA, including an app, as add-on to treatment as usual in young patients referred to Mental Health Services. We expect 356 families to participate from three designated Regions in Denmark.",[26],[453,454,455,456],"Internet-based intervention","Online therapy","Emotion regulation","ERITA","2025-03-07",{"date":459,"type":54},"2025-03-10",{"date":461,"type":54},"2022-02-01",{"date":117,"type":20},{"name":464,"class":96},"Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital",4,{"id":467,"slug":468,"hasResults":11,"nctId":469,"briefTitle":470,"officialTitle":470,"acronym":471,"eligibilityCriteria":472,"healthyVolunteers":11,"sex":15,"minAge":161,"maxAge":473,"enrollmentInfo":474,"targetDuration":4,"studyType":74,"phases":476,"briefSummary":477,"conditions":478,"keywords":4,"overallStatus":50,"whyStopped":4,"lastUpdateSubmitDate":480,"lastUpdatePostDateStruct":481,"startDateStruct":483,"completionDateStruct":485,"leadSponsor":486,"locationsCount":62},"100500459","therapeutic-evaluative-conditioning-to-reduce-adolescents-self-injurious-thoughts-and-behaviors-during-and-after-psychiatric-inpatient-hospitalization-100500459","NCT05796531","Therapeutic Evaluative Conditioning to Reduce Adolescents' Self-injurious Thoughts and Behaviors During and After Psychiatric Inpatient Hospitalization","TEC","Inclusion Criteria:\n\n* Be a patient on McLean-Franciscan Child and Adolescent Inpatient Program (MF-CAIP) of Franciscan Children's (FC)\n* Be 12-19 years-old\n* Own a smartphone\n* Have a parent\u002Fguardian that can provide permission\n* Child can assent\n* Presentation to the hospital with non-suicidal self-injury (NSSI), suicidal ideation or a suicide attempt.\n\nExclusion Criteria:\n\n* Any factor that impairs an individual's ability to comprehend and effectively participate in the study, including\n* an inability to speak or write English fluently\n* the presence of gross cognitive impairment due to florid psychosis, intellectual disability, dementia, acute intoxication, etc., or the presence of extremely agitated or violent behavior\n* a potential discharge location anticipated to be a residential program in which the average length of stay is more than 14 days","19 Years",{"count":475,"type":20},155,[76],"Suicide is the 2nd leading cause of death among adolescents, with the highest risk period for suicide being the month following psychiatric inpatient hospitalization. The investigators propose testing a brief, scalable intervention using evaluative conditioning aimed at reducing suicidal thoughts and behaviors among adolescents during and after inpatient hospitalization. Scalable interventions, such as the one proposed that reduce suicide risk during this markedly high-risk period, could result in large-scale decreases in suicide death.",[26,200,479],"Suicide Attempts","2024-07-10",{"date":482,"type":54},"2024-07-12",{"date":484,"type":54},"2023-03-31",{"date":117,"type":20},{"name":487,"class":96},"Franciscan Hospital For Children, INC."]